137 related articles for article (PubMed ID: 3489875)
1. "In vivo" visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates.
Hantraye P; Loc'h C; Tacke U; Riche D; Stulzaft O; Doudet D; Guibert B; Naquet R; Mazière B; Mazière M
Life Sci; 1986 Oct; 39(15):1375-82. PubMed ID: 3489875
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.
Bhargava HN; Perlow MJ
Toxicol Lett; 1988 Mar; 40(3):219-24. PubMed ID: 3258448
[TBL] [Abstract][Full Text] [Related]
3. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
[TBL] [Abstract][Full Text] [Related]
5. Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.
Chiueh CC; Firnau G; Burns RS; Nahmias C; Chirakal R; Kopin IJ; Garnett ES
Adv Neurol; 1987; 45():167-9. PubMed ID: 3103385
[No Abstract] [Full Text] [Related]
6. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Wiener HL; Lajtha A; Sershen H
Neuropharmacology; 1989 May; 28(5):535-7. PubMed ID: 2657481
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
[TBL] [Abstract][Full Text] [Related]
8. PET studies of functional compensation in a primate model of Parkinson's disease.
Eberling JL; Bankiewicz KS; Jordan S; VanBrocklin HF; Jagust WJ
Neuroreport; 1997 Aug; 8(12):2727-33. PubMed ID: 9295108
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ
Synapse; 1988; 2(5):469-73. PubMed ID: 3263709
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.
Lau YS; Fung YK
Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026
[TBL] [Abstract][Full Text] [Related]
11. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density.
Joyce JN; Marshall JF; Bankiewicz KS; Kopin IJ; Jacobowitz DM
Brain Res; 1986 Sep; 382(2):360-4. PubMed ID: 2944565
[TBL] [Abstract][Full Text] [Related]
12. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
[TBL] [Abstract][Full Text] [Related]
14. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL
Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015
[TBL] [Abstract][Full Text] [Related]
15. A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes.
Eberling JL; Jagust WJ; Taylor S; Bringas J; Pivirotto P; VanBrocklin HF; Bankiewicz KS
Brain Res; 1998 Sep; 805(1-2):259-62. PubMed ID: 9733979
[TBL] [Abstract][Full Text] [Related]
16. The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers.
Danielsen EH; Cumming P; Andersen F; Bender D; Brevig T; Falborg L; Gee A; Gillings NM; Hansen SB; Hermansen F; Johansen J; Johansen TE; Dahl-Jørgensen A; Jørgensen HA; Meyer M; Munk O; Pedersen EB; Poulsen PH; Rodell AB; Sakoh M; Simonsen CZ; Smith DF; Sørensen JC; Ostergård L; Zimmer J; Gjedde A; Møller A
Cell Transplant; 2000; 9(2):247-59. PubMed ID: 10811397
[TBL] [Abstract][Full Text] [Related]
17. Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.
Leenders KL; Aquilonius SM; Bergström K; Bjurling P; Crossman AR; Eckernas SA; Gee AG; Hartvig P; Lundqvist H; Långström B
Brain Res; 1988 Mar; 445(1):61-7. PubMed ID: 3259152
[TBL] [Abstract][Full Text] [Related]
18. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR
Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139
[TBL] [Abstract][Full Text] [Related]
19. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
[TBL] [Abstract][Full Text] [Related]
20. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T
Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
